Viatris
VIATRIS™ is a new kind of healthcare company, committed to providing access to medicines, advancing sustainable operations, developing innovative solutions and leveraging our collective expertise to improve patient outcomes. Formed in 2020 through the combination of Mylan and Upjohn, Viatris brings together best-in-class scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver quality medicines to patients when and where they need them.
Product Information
Satellite Symposium
Impact of Statins on CV Outcomes : It`s a Matter of Life and Death
Organized by CVRF and Supported by Educational Grant from Viatris
Saturday, April 24
12:30 PM ~ 1:31 PM * Korea Standard Time (UTC/GMT +9:00)
Main Arena (Channel 1)
Moderator(s): Doo Soo Jeon, Moo Hyun Kim
Panelist(s): Hyo-Suk Ahn
| 12:30 PM | Opening Remark Speaker: Doo Soo Jeon |
| 12:35 PM | Optimal Timing of High Intensity Statin in Patients with ACS Lecturer: Duk-Woo Park |
| 12:50 PM | Discussion |
| 1:00 PM | Lower for Longer: Important to Achieve LDL-C Target Focus on Cardiovascular Disease Lecturer: Kyung-Hee Kim |
| 1:15 PM | Discussion |
| 1:25 PM | Closing Remark Speaker: Moo Hyun Kim |